Skopos Labs, Inc. Charles River Laboratories International, Inc. Transaction History
Skopos Labs, Inc.
- $497 Million
- Q2 2025
A detailed history of Skopos Labs, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 178 shares of CRL stock, worth $31,837. This represents 0.01% of its overall portfolio holdings.
Number of Shares
178
Previous 178
-0.0%
Holding current value
$31,837
Previous $26,000
3.85%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding CRL
# of Institutions
637Shares Held
52.8MCall Options Held
1.42MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA5.81MShares$1.04 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$910 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.77MShares$674 Million0.11% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$390 Million0.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$332 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.1B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...